semaglutide and estrogen Hormone therapy may boost weight loss for postmenopausal women on Semaglutide and Menopause Weight Loss:
Description
The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes
Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, et al
The difference between stopping and continuing treatment is stark: discontinuation typically results in 5070% weight regain within 12 months, while continuous therapy preserves results
Additional heart health benefits Right now, Wegovy is the only weight loss injection proven and licensed to be used to reduce the risk of cardiac health problems , such as strokes and heart attacks, in people with obesity and heart disease
